- Home
- OUST vs AMLX Comparison
OUST vs AMLX Comparison
Compare OUST & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OUST
- AMLX
- Stock Information
- Founded
- OUST 2015
- AMLX 2014
- Country
- OUST United States
- AMLX United States
- Employees
- OUST N/A
- AMLX N/A
- Industry
- OUST Industrial Machinery/Components
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- OUST Technology
- AMLX Health Care
- Exchange
- OUST Nasdaq
- AMLX Nasdaq
- Market Cap
- OUST 422.4M
- AMLX 481.9M
- IPO Year
- OUST N/A
- AMLX 2022
- Fundamental
- Price
- OUST $8.44
- AMLX $4.76
- Analyst Decision
- OUST Strong Buy
- AMLX Buy
- Analyst Count
- OUST 5
- AMLX 7
- Target Price
- OUST $12.60
- AMLX $6.00
- AVG Volume (30 Days)
- OUST 1.3M
- AMLX 1.7M
- Earning Date
- OUST 11-07-2024
- AMLX 11-07-2024
- Dividend Yield
- OUST N/A
- AMLX N/A
- EPS Growth
- OUST N/A
- AMLX N/A
- EPS
- OUST N/A
- AMLX N/A
- Revenue
- OUST $105,453,000.00
- AMLX $196,485,000.00
- Revenue This Year
- OUST $35.77
- AMLX N/A
- Revenue Next Year
- OUST $38.06
- AMLX $149.49
- P/E Ratio
- OUST N/A
- AMLX N/A
- Revenue Growth
- OUST 51.14
- AMLX N/A
- 52 Week Low
- OUST $4.65
- AMLX $1.58
- 52 Week High
- OUST $16.88
- AMLX $19.95
- Technical
- Relative Strength Index (RSI)
- OUST 54.70
- AMLX 45.23
- Support Level
- OUST $7.27
- AMLX $4.88
- Resistance Level
- OUST $10.73
- AMLX $7.27
- Average True Range (ATR)
- OUST 0.70
- AMLX 0.59
- MACD
- OUST 0.11
- AMLX -0.18
- Stochastic Oscillator
- OUST 44.62
- AMLX 7.03
About OUST Ouster Inc.
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.